S
Shoichi Ozaki
Researcher at St. Marianna University School of Medicine
Publications - 123
Citations - 3538
Shoichi Ozaki is an academic researcher from St. Marianna University School of Medicine. The author has contributed to research in topics: Vasculitis & Microscopic polyangiitis. The author has an hindex of 32, co-authored 123 publications receiving 3213 citations. Previous affiliations of Shoichi Ozaki include Kyoto University & Juntendo University.
Papers
More filters
Journal ArticleDOI
A transgenic model of autoimmune hemolytic anemia.
Masaya Okamoto,Masao Murakami,Akira Shimizu,Shoichi Ozaki,Takeshi Tsubata,Shunichi Kumagai,Tasuku Honjo +6 more
TL;DR: This transgenic system providing a good autoimmune disease model for exploring its onset mechanism, and means of its treatment and prevention, and a wide variation of phenotypes between severe anemia and no symptoms.
Journal ArticleDOI
Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis
Yoshioki Yamasaki,Hidehiro Yamada,Masaomi Yamasaki,Michiko Ohkubo,Kohei Azuma,S. Matsuoka,Yasuyuki Kurihara,H. Osada,M. Satoh,Shoichi Ozaki +9 more
TL;DR: In this open-label study, IVCYC improved symptoms, pulmonary function tests and HRCT findings in patients with PM/DM and longitudinal controlled studies are required to further confirm the efficacy and safety ofIVCYC.
Journal ArticleDOI
Isolation and characterization of CA XIV, a novel membrane-bound carbonic anhydrase from mouse kidney.
Kiyoshi Mori,Yoshihiro Ogawa,Ken Ebihara,Naohisa Tamura,Kei Tashiro,Takashi Kuwahara,Masashi Mukoyama,Akira Sugawara,Shoichi Ozaki,Issei Tanaka,Kazuwa Nakao +10 more
TL;DR: The isolation of a novel CA from the mouse kidney by use of the signal sequence trap method is succeeded and a functional cDNA encoding a novel membrane-bound CA is cloned, which is designated CA XIV.
Journal ArticleDOI
ANCA-associated vasculitis: diagnostic and therapeutic strategy.
TL;DR: The diagnostic criteria and the recent evidence-based therapeutic strategy of AAV are described and it is indicated that the rate of remission induction by the standard regimen is approximately 90% in 6 months, that maintenance of remission can be achieved with oral azathioprine as well as cyclophosphamide, and that methotrexate can be used only for non-renal mild AAV.
Journal ArticleDOI
Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease.
Y. Imamura,Manae S. Kurokawa,Hideshi Yoshikawa,K. Nara,E. Takada,C. Masuda,S. Tsukikawa,Shoichi Ozaki,T. Matsuda,Noboru Suzuki +9 more
TL;DR: Th1‐dominant immune responses and HSP60 expression may induce the inflammatory responses and thus be associated with the pathogenesis of intestinal BD.